– USA, MA – Comet Therapeutics, a company built around the unique ability to re-engineer Coenzyme A-related metabolism, has raised $28.5 million in Series A funding to develop a broad portfolio of drug candidates.…
– USA, MA – Twentyeight-Seven Therapeutics today announced that Sofinnova Partners, a leading European venture capital firm specialized in the life sciences, has led the company’s Series A extension with a $15 million investment.…
– SWITZERLAND, Basel – Polyneuron Pharmaceuticals AG, a developer of a new class of biodegradable glycopolymers for the treatment of autoimmune diseases, today announced the closing of an oversubscribed CHF22.5 million Series A financing.…
– USA, MA – HotSpot Therapeutics, a new biotechnology company targeting nature’s regulatory hotspots to discover and develop first-in-class medicines, today announced the completion of a $45 million Series A financing.…
– FRANCE, Paris – LimFlow SA, developer of innovative, peripheral endovascular technology transforming the treatment of critical limb ischemia (CLI), today announced it has secured €27 million ($33.5 million) in an oversubscribed Series C financing.…